2[5]Brandon DD,Bethea CL,Strawn EY,et al.Progesterone receptor messenger ribonucleic acid and protein are overexpressed in human uterine leiomyomas.Am J Obstet Gyecol,1993,169(1):78
3[6]Cameron ST,Critchley HOD,Thong KJ,et al.Effects of daily low dose mifepristone on endometrial maturation and proliferation.Hum Reprod,1996,11(11):2518
4[7]Reinsch RC,Murphy AA,Morale AJ,et al.The effects of RU486 and leuprolide acete on uterine artery blood flow in the fibroid uterus: a prospective randomized study.Am J Obstet Gynecol,1994,170(9):1623
5[8]Dixon D,He H,Haseman JK.Immunohistochemical localization of growth factors and their receptors in uterine leiomyomas and matched myometrium.Environmental Health Perspectives,2000,108(Suppl 5):795
6[1]Brogden RN,Goa KL,Faulds D.Mifepristone-a review of its pharmacodynamic and pharmacokinetic properties,and therapeutic potential.Drugs,1993,45(3):384
7[2]Murphy AA,Kettel LM,Morales AJ,et al.Regression of uterine leiomyoma in response to the antiprogesterone RU486.J Clin Endocrinol Metab,1993,76(4):513
8[4]Kawaguchi D,Fujii S,Konishi I,et al.Ultrastructural study of cultured smooth muscle cells from uterine leiomyoma and myometrium under the influence of sex steroids.Gynecol Oncol,1985,21(1):32
9Buttram Jr VC, Reiter RC. Uterine leiomyomata: etiology,symptomatology, and management [ J ]. Fertil Steril, 1981,36:433.
10Rein Ma, Barbieri RL, Friedman AT. Progesterone: a critical role in the pathogenesis of uterine myomas[J]. Am J Obstet Gynecol, 1995,172:14.
